Similar articles

• The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.

  Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Pons E, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Jover R, et al. Eur J Cancer. 2009 Feb;45(3):365-73. doi: 10.1016/j.ejca.2008.07.016. Epub 2008 Aug 21. Eur J Cancer. 2009. PMID: 18722765
• Chemotherapy for operable and advanced colorectal cancer.

  Aschele C, Bergamo F, Lonardi S. Aschele C, et al. Cancer Treat Rev. 2009 Oct;35(6):509-16. doi: 10.1016/j.ctrv.2009.04.003. Epub 2009 May 29. Cancer Treat Rev. 2009. PMID: 19481872 Review.
• [Chemotherapy and hepatectomy for liver metastasis from colorectal cancer].

  Ohkubo T, Takayama T. Ohkubo T, et al. Gan To Kagaku Ryoho. 2009 Aug;36(8):1247-52. Gan To Kagaku Ryoho. 2009. PMID: 19692762 Review. Japanese.
• Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.

  Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG, Fernandez M, Evans CP, Koppie TM. Hellenthal NJ, et al. J Urol. 2009 Sep;182(3):900-6. doi: 10.1016/j.juro.2009.05.011. Epub 2009 Jul 17. J Urol. 2009. PMID: 19616245
• Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases: a ten year study.

  Karanjia ND, Lordan JT, Fawcett WJ, Quiney N, Worthington TR. Karanjia ND, et al. Eur J Surg Oncol. 2009 Aug;35(8):838-43. doi: 10.1016/j.ejso.2008.09.017. Epub 2008 Nov 17. Eur J Surg Oncol. 2009. PMID: 19010633